Characterization of human primary chondrocytes of osteoarthritic cartilage at varying severity

Chinese Medical Journal

Volumn 124, Issue 24, 2011, Pages 4245-4253

  Yin, Jing ^a   Yang, Zheng ^b   Cao, Yong Ping ^c   Ge, Zi Gang ^a  

^a PEKING UNIVERSITY   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Chondrocyte; Differentiation; Osteoarthritis

Indexed keywords

AGGRECAN; AGGRECANASE 2; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGENASE 3; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOSAMINOGLYCAN;

ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL COUNT; CELL DEDIFFERENTIATION; CELL PROLIFERATION; CELL SPREADING; CELL STRUCTURE; CELL YIELD; CELLULAR PARAMETERS; CONTROLLED STUDY; CYTOPATHOLOGY; DISEASE SEVERITY; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; OSTEOARTHRITIS; PATHOGENESIS; PROTEIN EXPRESSION;

ADAM PROTEINS; CARTILAGE; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; COLLAGEN TYPE X; GLYCOSAMINOGLYCANS; HUMANS; MATRIX METALLOPROTEINASE 13; OSTEOARTHRITIS;

EID: 84862970921     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.24.022     Document Type: Article

References (32)

1. Ge Z, Hu Y, Heng BC, Yang Z, Ouyang H, Lee EH, et al. Osteoarthritis and therapy. Arthritis Rheum 2006; 55: 493-500.
2. Bau B, Gebhard PM, Haag J, Knorr T, Bartnik E, Aigner T. Relative Messenger RNA expression profiling of collagenases and Aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 2002; 46: 2648-2657.
3. Lin Z, Fitzgerald JB, Xu J, Willers C, Wood D, Grodzinsky AJ, et al. Gene expression profiles of human chondrocytes during passaged monolayer cultivation. J Orthop Res 2008; 26: 1230-1237.
4. Brittberg M. Autologous chondrocyte implantation-technique and long-term follow-up. Injury 2008; 39 Suppl 1: s40-s49.
5. Aigner T, Soeder S, Gebhard PM, Mcalinden A, Haag J. Mechanisms of disease: role of chondrocytes in the pathogenesis of osteoarthritis-structure, chaos and senescence. Nat Clin Pract Rheumatol 2007; 3: 391-399.
6. Aigner T, Zien A, Gehrsitz A, Gebhard PM, Mckenna L. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 2001; 44: 2777-2789.
7. Sandell LJ, Heinegard D, Hering TM. Cell biology, biochemistry, and molecular biology of articular cartilage in osteoarthritis. osteoarthritis: diagnosis and medical/surgical management. 4th ed. Phaladephia: Lippincott Williams & Wilkins; 2007: 73-106.
8. Gebhard PM, Gehrsitz A, Bau B, Soder S, Eger W, Aigner T. Quantification of expression levels of cellular differentiation markers does not support a general shift in the cellular phenotype of osteoarthritic chondrocytes. J Orthop Res 2003; 21: 96-101.
9. Yagi R, Mcburney D, Laverty D, Weiner S, Horton WE. Intrajoint comparisons of gene expression patterns in human osteoarthritis suggest a change in chondrocyte phenotype. J Orthop Res 2005; 23: 1128-1138.
10. Fukui N, Ikeda Y, Ohnuki T, Tanaka N, Hikita A, Mitomi H, et al. Regional differences in chondrocyte metabolism in osteoarthritis: a detailed analysis by laser capture microdissection. Arthritis Rheum 2008; 58: 154-163.
11. Barbero A, Grogan S, Schafer D, Heberer M, Mainil-Varlet P, Martin I. Age related changes in human articular chondrocyte yield, proliferation and post-expansion chondrogenic capacity. Osteoarthritis Cartilage 2004; 12: 476-484.
12. Benya PD, Shaffer JD. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 1982; 30: 215-224.
13. Kawanishi M, Oura A, Furukawa K, Fukubayashi T, Nakamura K, Tateishi T, et al. Redifferentiation of dedifferentiated bovine articular chondrocytes enhanced by cyclic hydrostatic pressure under a gas-controlled system. Tissue Eng 2007; 13: 957-964.
14. Dell'Accio F, De Bari C, Luyten FP. Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. Arthritis Rheum 2001; 44: 1608-1619.
15. Dougados M, Ayral X, Listrat V, Gueguen A, Bahuaud J, Beaufils P, et al. The SFA system for assessing articular cartilage lesions at arthroscopy of the knee. Arthroscopy 1994; 10: 69-77.
16. Barbosa I, Garcia S, Barbier-Chassefiere V, Caruelle JP, Martelly I, Papy-Garcia D. Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies. Glycobiology 2003; 13: 647-653.
17. Ge ZG, Goh JCH, Lee EH. Selection of cell source for ligament tissue engineering. Cell Transpl 2005; 14: 573-583.
18. Chen FH, Rousche KT, Tuan RS. Technology insight: adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheum 2006; 2: 373-382.
19. von der Mark K, Gauss V, von der Mark H, Müller P. Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature 1977; 267: 531-532.
20. Marlovits S, Hombauer M, Truppe M, Vecsei V, Schlegel W. Changes in the ratio of type-i and type-ii collagen expression during monolayer culture of human chondrocytes. J Bone Joint Surg Br 2004; 86B: 286-295.
21. Sandell LJ, Aigner T Articular cartilage and changes in arthritis an introduction: cell biology of osteoarthritis. Arthritis Res 2001; 3: 107-113.
22. Mort JS, Billington CJ. Articular cartilage and changes in arthritis-matrix degradation. Arthritis Res 2001; 3: 337-341.
23. Tortorella MD, Burn TC, Pratta MA, Abbaszade I, Hollis JM, Liu R, et al. Purification and cloning of Aggrecanase-1: a member of the ADAMTS Family of proteins. Science 1999; 284: 1664-1666.
24. Arner EC, Pratta MA, Trzaskos JM, Decicco CP, Tortorella MD. Generation and characterization of Aggrecanase-a soluble, cartilage-derived Aggrecan-degrading activity. J Biol Chem 1999; 274: 6594-6601.
25. Stanton H, Rogerson FM, East CJ, Golub SB, Lawlor KE, Meeker CT, et al. ADAMTS5 is the major Aggrecanase in mouse cartilage in vivo and in vitro. Nature 2005; 434: 648-652.
26. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997; 99: 1534-1545.
27. Mtchell PG, Magna HA, Reeves LM, Loprestimorrow LL, Yocum SA, Rosner PJ, et al. Cloning, expression, and Type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996; 97: 761-768.
28. Aigner T, Bertling W, Stoss H, Weseloh G, von Der Mark K. Independent expression of fibril-forming collagens I, II, and III in chondrocytes of human osteoarthritic cartilage. J Clin Invest 1993; 91: 829-837.
29. Yang KG, Saris DB, Geuze RE, Van Rijen MH, Van Der Helm YJ, Verbout AJ, et al. Altered in vitro chondrogenic properties of chondrocytes harvested from unaffected cartilage in osteoarthritic joints. Osteoarthritis Cartilage 2006; 14: 561-570.
30. Bluteau G, Conrozier T, Mathieu P, Vignon E, Herbage D, Mallein-Gerin F. Matrix metalloproteinase-1, -3, -13 and Aggrecanase-1 and -2 are differentially expressed in experimental osteoarthritis. Biochim Biophys Acta 2001; 1526: 147-158.
31. Eerola I, Salminen H, Lammi P, Lammi M, von Der Mark K, Vuorio E, et al. Type X collagen, a natural component of mouse articular cartilage - association with growth, aging, and osteoarthritis. Arthritis Rheum 1998; 41: 1287-1295.
32. Schnabel M, Marlovits S, Eckhoff G, Fichtel I, Gotzen L, Vecsei V, et al. Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthritis Cartilage 2002; 10: 62-70.